BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma P, Sharma BC, Puri V, Sarin SK. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2009;104:885-90. [PMID: 19293781 DOI: 10.1038/ajg.2009.84] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Sarin SK, Khanna R. Non-cirrhotic Portal Hypertension. Clinics in Liver Disease 2014;18:451-76. [DOI: 10.1016/j.cld.2014.01.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
2 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 D’antiga L, Dacchille P, Boniver C, Poledri S, Schiff S, Zancan L, Amodio P. Clues for Minimal Hepatic Encephalopathy in Children With Noncirrhotic Portal Hypertension. Journal of Pediatric Gastroenterology & Nutrition 2014;59:689-94. [DOI: 10.1097/mpg.0000000000000537] [Cited by in Crossref: 14] [Article Influence: 1.8] [Reference Citation Analysis]
4 Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. J Gastroenterol Hepatol. 2016;31:1203-1209. [PMID: 26716736 DOI: 10.1111/jgh.13283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
5 Khanna R, Sarin SK. Idiopathic portal hypertension and extrahepatic portal venous obstruction. Hepatol Int. 2018;12:148-167. [PMID: 29464506 DOI: 10.1007/s12072-018-9844-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
6 Montgomery JY, Bajaj JS. Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep. 2011;13:26-33. [PMID: 20924726 DOI: 10.1007/s11894-010-0150-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
7 Sharma P, Sharma BC. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Saudi J Gastroenterol 2012;18:168-72. [PMID: 22626795 DOI: 10.4103/1319-3767.96448] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
8 Nicoletti V, Gioia S, Lucatelli P, Nardelli S, Pasquale C, Nogas Sobrinho S, Pentassuglio I, Greco F, De Santis A, Merli M, Riggio O. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors. Digestive and Liver Disease 2016;48:1072-7. [DOI: 10.1016/j.dld.2016.06.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
9 Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 2014;60:421-441. [PMID: 23978714 DOI: 10.1016/j.jhep.2013.08.013] [Cited by in Crossref: 170] [Cited by in F6Publishing: 127] [Article Influence: 18.9] [Reference Citation Analysis]
10 Khanna R, Sarin SK. Noncirrhotic Portal Hypertension: Current and Emerging Perspectives. Clin Liver Dis. 2019;23:781-807. [PMID: 31563222 DOI: 10.1016/j.cld.2019.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Alfawaz HA, Aljumah AA. What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides? Saudi J Gastroenterol 2012;18:153-4. [PMID: 22626793 DOI: 10.4103/1319-3767.96443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Kumar A, Sharma P, Arora A. Review article: portal vein obstruction - epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015;41:276-92. [DOI: 10.1111/apt.13019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
13 Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, Duseja A, Aggarwal R, Amarapurkar D, Sharma P, Madan K, Shah S, Seth AK, Gupta RK, Koshy A, Rai RR, Dilawari JB, Mishra SP, Acharya SK. Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver: Minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2010;25:1029-41. [DOI: 10.1111/j.1440-1746.2010.06318.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
14 Valla DC, Cazals-Hatem D. Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts. Virchows Arch. 2018;473:3-13. [PMID: 29572606 DOI: 10.1007/s00428-018-2331-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 Lautz TB, Keys LA, Melvin JC, Ito J, Superina RA. Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children. J Am Coll Surg. 2013;216:83-89. [PMID: 23177370 DOI: 10.1016/j.jamcollsurg.2012.09.013] [Cited by in Crossref: 72] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]